Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
high-resolution imaging. Characterize tissue- and cell-specific RNA dynamics to inform the design of optimized RNA constructs. Contribute to the preclinical development of local gene-editing strategies
-
Framework Programme? Horizon Europe - ERC Reference Number HE-ERC-2023-CoG-10123888-SCRIBE M.Güell:RNA-based gene writi Is the Job related to staff position within a Research Infrastructure? No Offer
-
. Expertise in any of the following fields would be beneficial: mass spectrometry, protein purification, gene editing/cell engineering, structural biology. Additional Qualifications Special Instructions
-
and gene therapy. Our laboratory is established at the Institute for Regenerative Medicine https://www.irem.uzh.ch/en.html, a leading research institute of the University of Zurich (UZH) at the life
-
biological sciences or a related field. Proficiency in genomic technologies and gene editing, as well as competency in computational analyses of high-throughput sequencing data, is expected. The candidate must
-
focus on designing CRISPR editing gene strategies, infecting corn and soybean plants with viruses, recording data, documenting results, writing reports and manuscripts, assisting with grant writing, and
-
optimization of Gene Editing vectors and their delivery to target specific loci in the human genome in collaboration with different world-renowned research laboratories specialized in rare diseases and oncology
-
significant potential for adaptation to these challenging environments. Additionally, we have identified key gene families and their specific targets that can be enhanced through genome editing technologies
-
diagnosis and treatment of patients suffering severe primary immunodeficiency disorders. A major focus of our lab is understanding gene regulation and identifying non-coding, disease-causing variants
-
University of Massachusetts Medical School | Worcester, Massachusetts | United States | about 4 hours ago
editing systems tailored to correct gene mutations common in certain patient populations or kill cancer cells. Participate in the application of these genome editing systems in relevant mouse disease models